The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Chlamydia trachomatis and invasive cervical cancer: A pooled analysis of the IARC multicentric case‐control study
Open accessAbstract
To determine whether Chlamydia trachomatis infection is consistently associated with an increased risk of invasive cervical carcinoma (ICC) after accounting for the strong effect of human papillomavirus (HPV) infection, a case‐control study of 1,238 cases of ICC and 1,100 control women from 7 countries was carried out (hospital‐based studies in Thailand, the Philippines, Morocco, Peru, Brazil and population‐based studies in Colombia and Spain, all coordinated by the International Agency for Research on Cancer, Lyon, France). C. trachomatis serum antibody detection was made by means of a microfluorescence assay. Among HPV DNA‐positive cases and controls, the risk of squamous cell ICC was elevated in C. trachomatis seropositive women (OR = 1.8; 95% CI = 1.2–2.7) after adjustment for age, center, oral contraceptive use, history of Pap smears, number of full‐term pregnancies and herpes simplex virus 2 seropositivity. The effect of C. trachomatis seropositivity on squamous cell ICC risk increased with increasing C. trachomatis antibody titers and was higher in women under 55 years of age. C. trachomatis antibodies were not associated with adeno‐ or adenosquamous cell carcinoma (OR = 1.0; 95% CI = 0.53–1.9) in HPV DNA‐positive women. An association of C. trachomatis with squamous cell ICC was found among all cases and control women with or without adjustment for HPV. © 2004 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
Zuckerman, A. J. (1995) · Journal of Clinical Pathology · doi:10.1136/jcp.48.7.691-a · Cited by 8,728
Statistical Methods in Cancer Research
Breslow, N. E. (1980) · Cited by 7,332
Statistical methods in cancer research. Volume I - The analysis of case-control studies.
Breslow, N. E., & Day, N. E. (1980) · PubMed · Cited by 4,988
Harrison's Principles of Internal Medicine
Verghese, A. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03520080084052 · Cited by 1,361
Moreno, V., Bosch, F. X., Muñoz, N., Meijer, C. J., Shah, K. V., Walboomers, J. M., Herrero, R., & Franceschi, S. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08150-3 · Cited by 692
Self-citationRole of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study
Muñoz, N., Franceschi, S., Bosetti, C., Moreno, V., Herrero, R., Smith, J. S., Shah, K. V., Meijer, C. J., & Bosch, F. X. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08151-5 · Cited by 684
Self-citationFan, T., Lu, H., Hu, H., Shi, L., McClarty, G. A., Nance, D. M., Greenberg, A. H., & Zhong, G. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.487 · Cited by 587
Munoz, N., Bosch, F. X., de Sanjose, S., Tafur, L., Izarzugaza, I., Gili, M., Viladiu, P., Navarro, C., Martos, C., Ascunce, N., et al. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910520513 · Cited by 568
Self-citationSerotypes of Chlamydia trachomatis and Risk for Development of Cervical Squamous Cell Carcinoma
Anttila, T. (2001) · JAMA · doi:10.1001/jama.285.1.47 · Cited by 359
Chlamydia trachomatis infection as a risk factor for invasive cervical cancer
Koskela, P., Anttila, T., Bjørge, T., Brunsvig, A., Dillner, J., Hakama, M., Hakulinen, T., Jellum, E., Lehtinen, M., Lenner, P., et al. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000101)85:1<35::aid-ijc6>3.0.co;2-a · Cited by 301
Human papillomavirus and invasive cervical cancer in Brazil
Eluf-Neto, J., Booth, M., Muñoz, N., Bosch, F., Meijer, C., & Walboomers, J. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.18 · Cited by 268
Self-citationCastle, P. E., Hillier, S. L., Rabe, L. K., Hildesheim, A., Herrero, R., Bratti, M. C., Sherman, M. E., Burk, R. D., Rodriguez, A. C., Alfaro, M., et al. (2001) · PubMed · Cited by 249
Self-citationRisk Factors for Cervical Cancer in Thailand: a Case-Control Study
Chichareon, S., Herrero, R., Muñoz, N., Bosch, F. X., Jacobs, M. V., Deacon, J., Santamaria, M., Chongsuvivatwong, V., Meijer, C. J. L. M., & Walboomers, J. M. M. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.1.50 · Cited by 226
Self-citationCauses of Cervical Cancer in the Philippines: a Case-Control Study
Ngelange, C., Muñoz, N., Bosch, F. X., Festin, M. R., Deacon, J., Jacobs, M. V., Santamaria, M., Meijer, C. J. L. M., & Walboomers, J. M. M. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.1.43 · Cited by 177
Self-citationA population‐based prospective study of Chlamydia trachomatis infection and cervical carcinoma
Wallin, K., Wiklund, F., Luostarinen, T., Ångström, T., Anttila, T., Bergman, F., Hallmans, G., Ikäheimo, I., Koskela, P., Lehtinen, M., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10639 · Cited by 176
Smith, J. S., Muñoz, N., Herrero, R., Eluf‐Neto, J., Ngelangel, C., Franceschi, S., Bosch, F. X., Walboomers, J. M. M., & Peeling, R. W. (2002) · The Journal of Infectious Diseases · doi:10.1086/338569 · Cited by 171
Self-citationLehtinen, M., Dillner, J., Knekt, P., Luostarinen, T., Aromaa, A., Kirnbauer, R., Koskela, P., Paavonen, J., Peto, R., Schiller, J. T., et al. (1996) · BMJ · doi:10.1136/bmj.312.7030.537 · Cited by 162
The viral origin of cervical cancer in Rabat, Morocco
Chaouki, N., Bosch, F. X., Muñóz, N., Meijer, C. J. L. M., Gueddari, B. E., Ghazi, A. E., Deacon, J., Castellsagué, X., & Walboomers, J. M. M. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980209)75:4<546::aid-ijc9>3.0.co;2-t · Cited by 160
Self-citationHuman papillomavirus in a necessary cause of invasive cervical cancer worldwide
(1999) · Pure Amsterdam UMC · doi:10.1002/(sici)1096-9896(199909)189:1 · Cited by 140
Role of nitric oxide in genotoxicity: Implication for carcinogenesis
Felley‐Bosco, E. (1998) · Cancer and Metastasis Reviews · doi:10.1023/a:1005948420548 · Cited by 139
Sexually transmitted agents and cervical neoplasia in colombia and Spain
de Sanjosé, S., Muñóz, N., Bosch, F. X., Reimann, K., Pedersen, N. S., Orfila, J., Ascunce, N., González, L. C., Tafur, L., Gili, M., et al. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910560311 · Cited by 135
Self-citationHPV types and cofactors causing cervical cancer in Peru
Santos, C., Muñóz, N., Klug, S. J., Almonte, M., Guerrero, I., Alvarez, M., Velarde, C., Kajatt, O. G., Castillo, M., Walboomers, J. M. M., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1948 · Cited by 120
Self-citationPersistence of chlamydial antibodies after pelvic inflammatory disease
Puolakkainen, M. H., Vesterinen, E. H., Purola, E., Saikku, P., & Paavonen, J. A. (1986) · Journal of Clinical Microbiology · doi:10.1128/jcm.23.5.924-928.1986 · Cited by 106
Prozialeck, W. C., Fay, M. J., Lamar, P. C., Pearson, C. A., Sigar, I. M., & Ramsey, K. H. (2002) · Infection and Immunity · doi:10.1128/iai.70.5.2605-2613.2002 · Cited by 99
How to use Chlamydia antibody testing in subfertility patients
Land, J. A., Evers, J. L. H., & Goossens, V. J. (1998) · Human Reproduction · doi:10.1093/humrep/13.4.1094 · Cited by 99
A population-based seroepidemiological study of cervical cancer.
Dillner, J., Lenner, P., Lehtinen, M., Eklund, C., Heino, P., Wiklund, F. E., Hallmans, G., & Stendahl, U. (1994) · PubMed · Cited by 93
Jha, P., Beral, V., Pike, M. C., Hermon, C., Peto, J., Deacon, J., Chilvers, C. E. D., Vessey, M. P., Mant, D., Gissmann, L., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)93128-n · Cited by 74
Smith, J. S., Herrero, R., Mu�oz, N., Eluf‐Neto, J., Ngelangel, C., Bosch, F. X., & Ashley, R. L. (2001) · Sexually Transmitted Diseases · doi:10.1097/00007435-200104000-00001 · Cited by 53
Self-citationPowles, T. J. (2002) · The Oncologist · doi:10.1634/theoncologist.7-1-60 · Cited by 52
Chlamydia trachomatis and Cervical Squamous Cell Carcinoma
Morré, S. A., & Ossewaarde, J. M. (2001) · JAMA · doi:10.1001/jama.285.13.1703 · Cited by 33
The rapid assessment of fatigue severity in cancer patients
Mendoza, T. R., Wang, X. S., Cleeland, C. S., Morrissey, M., Johnson, B. A., Wendt, J. K., & Huber, S. L. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990301)85:5 · Cited by 1
Cited by
Human papillomavirus and cervical cancer
Schiffman, M., Castle, P. E., Jeronimo, J., Rodriguez, A. C., & Wacholder, S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61416-0 · Cited by 2,985
The global health burden of infection‐associated cancers in the year 2002
Parkin, D. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21731 · Cited by 2,932
Case–Control Study of Human Papillomavirus and Oropharyngeal Cancer
D'Souza, G., Kreimer, A. R., Viscidi, R., Pawlita, M., Fakhry, C., Koch, W. M., Westra, W. H., & Gillison, M. L. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065497 · Cited by 2,692
Chapter 1: HPV in the etiology of human cancer
Muñoz, N., Castellsagué, X., de González, A. B., & Gissmann, L. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.115 · Cited by 1,355
Carcinogenic human papillomavirus infection
Schiffman, M., Doorbar, J., Wentzensen, N., de Sanjosé, S., Fakhry, C., Monk, B. J., Stanley, M. A., & Franceschi, S. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.86 · Cited by 999
Self-citation
Metadata
- Authors
- Smith, J. S., Bosetti, C., Muñoz, N., Herrero, R., Bosch, F. X., Eluf‐Neto, J., Meijer, C. J. L. M., van den Brule, A. J. C., Franceschi, S., & Peeling, R. W.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2004-04-23
- Volume
- 111
- Issue
- 3
- Pages
- 431-439
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2091844322
- Cited by
- 278
- References
- 31
- FWCI
- 11.25
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.